BASKING RIDGE, N.J. , May 9, 2014 /PRNewswire/ -- Regado Biosciences, Inc. (Nasdaq: RGDO) , a biopharmaceutical company focused on the late-stage clinical development of its first-in-class, actively controllable antithrombotic drug system, REG1, today announced that the Compensation Committee of Regado's Board of Directors granted an inducement award pursuant to NASDAQ Listing Rule 5635(c)(4) to R.
LOS ANGELES, May 20, 2014 (GLOBE NEWSWIRE) -- Daily Journal Corporation (Nasdaq:DJCO) announced today that, due to the delayed filing of its quarterly report on Form 10-Q for the fiscal quarter ended March 31, 2014, the Company received, as expected, a notification letter from The NASDAQ Stock Market stating that the Company is not in compliance with NASDAQ Stock Market Rule 5250(c)(1), which requires the timely filing of all required periodic financial reports with the Securities and Exchange Commission ("SEC"). The NASDAQ letter was issued in accordance with standard NASDAQ procedures.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.